Copyright
©2012 Baishideng.
World J Psychiatr. Oct 22, 2012; 2(5): 74-82
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Direct | Indirect |
Detection of the drug or drug metabolites | Objective |
Direct observation | Tablet count |
Electronic monitoring | |
Pharmacy records | |
Subjective | |
Psychometric scales | |
Questioning the patient | |
Questioning the relatives | |
Clinical judgment |
Patient-related risk factors |
Sociodemographic factors |
Younger and older patients |
Male |
General clinical factors |
Drugs or alcohol consumption |
Previous non-adherence |
Psychopathological symptoms |
Impaired insight |
Cognitive deficiency |
Delusion of persecution, poisoning or grandeur |
Psychotic symptoms |
Negative symptoms |
Psychological factors: attitudes, beliefs and other subjective aspects |
Negative attitude toward the treatment |
Negative subjective response to treatment |
Regarding the disease as mild and/or perceived minor benefit from treatment |
Shame or stigmatization associated with the medication or the disease |
Environment-related risk factors |
Poor social and familial support |
Negative social perception of the disease |
Stigmatization |
Difficulty accessing healthcare services |
Physician-related risk factors |
Poor relationship with the therapist |
Poor psychoeducation and information to patients and relatives |
Poor contact with the therapist |
Inadequate planning of the post-discharge period |
Treatment-related risk factors |
Ineffectiveness against persistent symptoms (psychotic and negative symptoms) |
Fear of adverse effects |
Complex medication schedule |
Poorer adherence to oral than to intramuscular treatments |
- Citation: Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatr 2012; 2(5): 74-82
- URL: https://www.wjgnet.com/2220-3206/full/v2/i5/74.htm
- DOI: https://dx.doi.org/10.5498/wjp.v2.i5.74